Join
Live feed
·
PRReleasevia Quantisnow
Annovis Bio Inc. logo

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

ByQuantisnow·Wall Street's wire, on your screen.
ANVS· Annovis Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANVS (Annovis Bio Inc.) and more on Quantisnow.